#5 - Curaleaf (OTCMKTS:CURLF)
Cannabis stocks are still a risky play and Curaleaf Holdings Inc. (OTCMKTS: CURLF) is no exception. However, the industry stands to benefit as it seems increasingly likely that marijuana will be classified as a less restrictive Schedule III drug. The Biden administration took an initial step towards reclassification and Donald Trump has expressed support, so the progress should move forward regardless of the outcome of November’s election.
Additionally, Curaleaf continues to expand its operations internationally, particularly in Europe. That’s significant because countries like Germany have already legalized cannabis. That will provide another revenue stream for a company that has gotten stagnant in that category.
Then there’s the CURLF stock price which is down 27% in 2024. Analysts have a $6.25 price target on the stock, which is 111% higher than the stock’s price on September 11, 2024. One note of caution, as an over-the-counter security, CURLF stock may not be available through every online broker or trading platform.
About Curaleaf
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Read More - Current Price
- $2.02
- Consensus Rating
- Buy
- Ratings Breakdown
- 2 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $6.25 (209.4% Upside)
